WallStreetZenWallStreetZen

NASDAQ: AVTE
Aerovate Therapeutics Inc Stock Ownership - Who owns Aerovate Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aerovate Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin T. DakeOfficer Title President Chief Operating Officer and Secretary2024-08-011,507$1.74
$2.62kBuy
Benjamin T. DakeOfficer Title President Chief Operating Officer and Secretary2024-07-3111,454$1.74
$19.93kBuy
Ra Capital Management LPDirector2024-06-17928,110$1.67
$1.55MBuy
Marinus VerwijsCHIEF TECHNICAL OFFICER2024-06-1410,600$14.59
$154.65kBuy
George A. EldridgeOfficer Title Chief Financial Officer and Treasurer2024-06-1415,000$25.03
$375.45kSell
George A. EldridgeOfficer Title Chief Financial Officer and Treasurer2024-06-1415,000$2.14
$32.10kBuy
Marinus VerwijsCHIEF TECHNICAL OFFICER2024-06-1410,600$25.00
$265.00kSell
Hunter GilliesCHIEF MEDICAL OFFICER2024-06-136,000$24.50
$147.00kSell
Hunter GilliesCHIEF MEDICAL OFFICER2024-06-136,000$2.14
$12.84kBuy
Hunter GilliesCHIEF MEDICAL OFFICER2024-05-174,000$2.14
$8.56kBuy

1 of 2

AVTE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVTE insiders and whales buy or sell their stock.

AVTE Shareholders

What type of owners hold Aerovate Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP31.71%9,192,092$24.63MInstitution
Sofinnova Investments Inc12.97%3,758,686$10.07MInstitution
Sofinnova Venture Partners X LP12.97%3,758,686$10.07MInsider
Maha Katabi12.97%3,758,686$10.07MInsider
Atlas Venture Fund XII LP8.03%2,327,909$6.24MInsider
Tcg Crossover Management LLC7.73%2,240,809$6.01MInstitution
Cormorant Asset Management LP7.01%2,030,691$5.44MInsider
David S. Grayzel6.21%1,799,232$4.82MInsider
Atlas Venture Life Science Advisors LLC6.21%1,799,232$4.82MInstitution
Braidwell LP4.97%1,440,499$3.86MInstitution

1 of 3

AVTE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVTE68.37%31.63%Net Buying
CNTX81.14%1.29%
UNCY51.54%11.83%
ELTX2.85%70.59%Net BuyingNet Buying
NTRB2.20%50.83%
View Top Biotech Stocks

Aerovate Therapeutics Stock Ownership FAQ

Who owns Aerovate Therapeutics?

Aerovate Therapeutics (NASDAQ: AVTE) is owned by 104.07% institutional shareholders, 48.14% Aerovate Therapeutics insiders, and 0.00% retail investors. Sofinnova Venture Partners X LP is the largest individual Aerovate Therapeutics shareholder, owning 3.76M shares representing 12.97% of the company. Sofinnova Venture Partners X LP's Aerovate Therapeutics shares are currently valued at $10.07M.

If you're new to stock investing, here's how to buy Aerovate Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.